Researchers have discovered a class of lipids that prevent or reverse some of the harmful metabolic changes of diabetes and similar disorders in mice. These molecules might be therapeutic themselves, or they could lead researchers to new drugs. Barbara Kahn, George Richards Minot Professor of Medicine at Beth Israel Deaconess Medical Center, led the research.
